Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026
This week, biopharma companies including Biogen, Bristol Myers Squibb and Roche are in Boston with new data on their efforts to tackle Alzheimer’s disease.
This week, biopharma companies including Biogen, Bristol Myers Squibb and Roche are in Boston with new data on their efforts to tackle Alzheimer’s disease.
comments(0)
5-min edit window · permanent after that